91402-77-6

Upstream product

• 719-59-5 5-chloro-2-aminobenzophenone 
• 103143-95-9 2-N-(N'-Boc-D-tryptophanyl)amino-5-chlorobenzophenone 
• 5241-64-5 Boc-D-Trp-OH 
• 14907-27-8 (R)-(+)-tryptophan methyl ester hydrochloride 

Downstream Products

• 103343-14-2 (R)-3-(1-Benzyl-1H-indol-3-ylmethyl)-7-chloro-1-methyl-5-phenyl-1,3-dihydro-benzo[e][1,4]diazepin-2-one 
• 103343-01-7 7-Chloro-1,3-Dihydro-3(R)-(3'-indolyl)methyl-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one 
• 103342-95-6 7-chloro-1,3,4,5-tetrahydro-3(R)-(1H-indol-3-ylmethyl)-5-phenyl-2H-1,4-benzodiazepin-2-one 
• 103343-24-4 (R)-7-chloro-3-((2,3-dihydro-2-oxo-1H-indol-3-yl)methyl)-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one 
• 103343-04-0 (R)-7-chloro-1,3-dihydro-3-(1H-indol-3-ylmethyl)-5-phenyl-2H-1,4-benzodiazepine-2-thione 
• 103343-00-6 (R)-1-Benzyl-7-chloro-3-(1H-indol-3-ylmethyl)-5-phenyl-1,3-dihydro-benzo[e][1,4]diazepin-2-one 

Relevant academic research and scientific papers

Discrimination between enantiomers of structurally related molecules: Separation of benzodiazepines by molecularly imprinted polymers

Molecular imprinting has been used to create synthetic receptor sites for a series of chiral benzodiazepines. A detailed HPLC analysis of binding properties using molecularly imprinted polymers (MIPs) as the stationary phase showed that binding, as measur

Benzodiazepine analogs

Benzodiazepine analogs of the formula: STR1 are disclosed which are antagonists of gastrin and cholecystokinin (CCK).

Design of Nonpeptidal Ligands for a Peptide Receptor: Cholecystokinin Antagonists

A series of 3-substituted-5-phenyl-1,4-benzodiazepines, nonpeptidal antagonists of the peptide hormone cholecystokinin (CCK), have been synthesized.Designed on the basis of facts regarding CCK, its natural-product antagonist asperlicin (3), and the antian